To explore the mechanisms behind radioresistance in tumors, a previous study performed RNA-seq on A549 human lung adenocarcinoma cells after radiotherapy and found that Cyclin-Dependent Kinase Inhibitor 1A (CDKN1A) is highly expressed. Here, CDKN1A is linked to lung adenocarcinoma.